Qualifications

• Ph.D., Medicinal Chemistry, September 2021. University de Tours, France.
• Master of Pharmacy in Medicinal Chemistry, March 2016. University of Gezira, Faculty of Pharmacy, Sudan.
• Bachelor of Pharmacy, March 2010. University of Gezira, Faculty of Pharmacy, Sudan.

Experience

• Assistant professor of pharmaceutical chemistry, RACOP, UMHSU, from September 2024-present.
• Assistant professor of pharmaceutical chemistry, Faculty of Pharmacy, University of Gezira, Sudan, from September 2021-September 2024.
• Lecturer of pharmaceutical chemistry, Faculty of Pharmacy, University of Gezira, Sudan, from April 2016-September 2021.
• Teaching Assistant of pharmaceutical chemistry, Faculty of Pharmacy, University of Gezira, Sudan, from December 2015-April 2016.

Courses Taught

• Innovations & Entrepreneurship in Pharmacy (PIE503)
• General Chemistry for Pharmacy (PGC-103P)
• Pharmaceutical Calculations (PPC203)
• Pharmaceutical Analysis-1 (PRA213)

Publications

• Repurposing of approved drugs for targeting CDK4/6 and aromatase protein using molecular docking and molecular dynamics studies.
• Exploring the potential of approved drugs for triple-negative breast cancer treatment by targeting casein kinase 2: Insights from computational studies.
• Identification of Novel Natural Dual HDAC and Hsp90 Inhibitors for Metastatic TNBC Using e-Pharmacophore Modeling, Molecular Docking, and Molecular Dynamics Studies.
• Insights into the Inhibition of Mycolic Acid Synthesis by Cytosporone E Derivatives for Tuberculosis Treatment Via an In Silico Multi-target Approach.
• Design of Novel Phosphatidylinositol 3-Kinase Inhibitors for Non-Hodgkin's Lymphoma: Molecular Docking, Molecular Dynamics, and Density Functional Theory Studies on Gold Nanoparticles.
• Cytosporone E analogues as BRD4 inhibitors for cancer treatment: Molecular docking and molecular dynamic investigations.
• Drug repurposing against main protease and RNA-dependent RNA polymerase of SARS-CoV-2 using molecular docking, MMGBSA calculations, and molecular dynamics.
• Phthalide Derivatives as Dihydrofolate Reductase Inhibitors for Malaria: Molecular Docking and Molecular Dynamics.
• Drug repurposing for SARS-CoV-2 main protease: Molecular docking and molecular dynamics investigations.
• Design of Novel Coumarins as Potent Mcl-1 Inhibitors for Cancer Treatment Guided by 3D-QSAR, Molecular Docking and Molecular Dynamics.
• Identification of Novel Transmembrane Protease Serine Type 2 Drug Candidates for COVID-19 Using Computational Studies.
• Synthesis, antibacterial and cytotoxic evaluation of cytosporone E and analogs.
• Synthesis and antibacterial activity of racemic paecilocin A and its derivatives against methicillin-sensitive and -resistant Staphylococcus aureus.

Achievements

• PhD scholarship at Laboratoire Synthese et Isolement de Molecules Bioactives (SIMBA, EA 7502), University de Tours, Tours, France. Sponsored by: Ministry of Higher Education (Sudan) and French Government.